The past 20 years have seen a rapid increase in our understanding of the biology of cancer. And, advances in understanding the genetics of cancer are beginning to have an impact on the clinical management of malignant disease. Many of the genetic changes that underlie malignant transformation of cells and/or that distinguish malignant clones can be used as markers to diagnose, monitor, or characterize various forms of cancer. The purpose of this volume is to assess the current status of genetic testing in cancer management both from the standpoint of those tests and genetic markers that are presently available and from the perspective of genetic approaches to cancer testing that are likely to have an impact on cancer management in the near future.
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Division of Health Sciences Policy, and Medicine Roundtable on Environmental Health Sciences, Research, Christine Coussens, Kathi Hanna
Institute of Medicine, Division of Health Sciences Policy, Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Daniel Federman, Ruth Faden, Anna C. Mastroianni
Institute of Medicine, Division of Health Sciences Policy, Committee on Addressing Career Paths for Clinical Research, Mark A. Randolph, William N. Kelley
Institute of Medicine, Division of Health Sciences Policy, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Jonathan R. Davis, Sarah Pitluck, Peter Bouxsein, Ronald W. Estabrook, M.D. Yaffe, Sumner
Institute of Medicine, Division of Biobehavioral Sciences and Mental Disorders, Division of Health Sciences Policy, Committee on a National Neural Circuitry Database, Joseph B. Martin, Constance M. Pechura